According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -0,05265ย โฌ. In 2022 the company made an earnings per share (EPS) of -0,07020ย โฌ an increase over its 2021 EPS that were of -0,13ย โฌ.